| |
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Alimentos e Territórios. Para informações adicionais entre em contato com mara.petrocchi@embrapa.br. |
|
Registro Completo |
|
Biblioteca(s): |
Embrapa Alimentos e Territórios. |
|
Data corrente: |
08/04/2026 |
|
Data da última atualização: |
08/04/2026 |
|
Tipo da produção científica: |
Artigo em Periódico Indexado |
|
Autoria: |
YE, KE; CÂNDIDO, F. G.; RAMOS, J. DE S.; GUILARDUCCI, M. J.; GUIMARÃES, N. S.; LIU, H.; GOMES, J. M. G. |
|
Afiliação: |
KE YE, BENGBU MEDICAL UNIVERSITY; FLAVIA GALVAO CANDIDO, CNAT; JULIANA DE SOUZA RAMOS, INSTITUTO FEDERAL DE EDUCAÇÃO, CIÊNCIA E TECNOLOGIA DO SUDESTE DE MINAS GERAIS; MARIANA JULIÃO GUILARDUCCI, UNIVERSIDADE DE SÃO PAULO; NATHALIA SERNIZON GUIMARÃES, UNIVERSIDADE FEDERAL DE MINAS GERAIS; HUAQING LIU, BENGBU MEDICAL UNIVERSITY; JÚNIA MARIA GERALDO GOMES, INSTITUTO FEDERAL DE EDUCAÇÃO, CIÊNCIA E TECNOLOGIA DO SUDESTE DE MINAS GERAIS. |
|
Título: |
Effects of pumpkin (Cucurbita spp.) on glycemic and type 2 diabetes-related metabolic biomarkers: a systematic review of controlled clinical trials. |
|
Ano de publicação: |
2026 |
|
Fonte/Imprenta: |
Nutrition Reviews, nuag027, apr. 2026. |
|
DOI: |
https://doi.org/10.1093/nutrit/nuag027 |
|
Idioma: |
Inglês |
|
Conteúdo: |
Context Pumpkin (Cucurbita spp.) is a versatile, low-cost, widely used plant product with potential to promote glycemic control. However, clinical evidence regarding its antihyperglycemic efficacy remains inconsistent. Objective The primary aim was to investigate the antihyperglycemic effects of pumpkin in human nutrition; the secondary aim was to assess pumpkin’s impact on type 2 diabetes mellitus (T2DM)-related metabolic biomarkers. Data Source A systematic review was performed by searching databases (MEDLINE/PubMed, Embase, and Cochrane Library/Central) until March 2025 and included controlled clinical trials assessing the effects of pumpkin or its by-products on glucose outcomes and T2DM-related metabolic biomarkers in adults with or without T2DM. Data Extraction All studies were independently screened and extracted by 2 researchers. In the case of disagreement, a third researcher was consulted. Data Analysis From 198 records screened, 9 controlled clinical trials (n = 316 participants) were selected for qualitative analysis. Conclusions Pumpkin and its by-products have potential to be used as adjuvants in the prevention and/or treatment of T2DM. More high-quality and long-term clinical trials are needed to confirm this evidence. |
|
Palavras-Chave: |
Fasting blood glucose. |
|
Thesaurus Nal: |
Cucurbita; Diabetes mellitus; Glycemic control; Pumpkins. |
|
Categoria do assunto: |
Q Alimentos e Nutrição Humana |
|
Marc: |
LEADER 02090naa a2200265 a 4500
001 2186188
005 2026-04-08
008 2026 bl uuuu u00u1 u #d
024 7 $ahttps://doi.org/10.1093/nutrit/nuag027$2DOI
100 1 $aYE, KE
245 $aEffects of pumpkin (Cucurbita spp.) on glycemic and type 2 diabetes-related metabolic biomarkers$ba systematic review of controlled clinical trials.$h[electronic resource]
260 $c2026
520 $aContext Pumpkin (Cucurbita spp.) is a versatile, low-cost, widely used plant product with potential to promote glycemic control. However, clinical evidence regarding its antihyperglycemic efficacy remains inconsistent. Objective The primary aim was to investigate the antihyperglycemic effects of pumpkin in human nutrition; the secondary aim was to assess pumpkin’s impact on type 2 diabetes mellitus (T2DM)-related metabolic biomarkers. Data Source A systematic review was performed by searching databases (MEDLINE/PubMed, Embase, and Cochrane Library/Central) until March 2025 and included controlled clinical trials assessing the effects of pumpkin or its by-products on glucose outcomes and T2DM-related metabolic biomarkers in adults with or without T2DM. Data Extraction All studies were independently screened and extracted by 2 researchers. In the case of disagreement, a third researcher was consulted. Data Analysis From 198 records screened, 9 controlled clinical trials (n = 316 participants) were selected for qualitative analysis. Conclusions Pumpkin and its by-products have potential to be used as adjuvants in the prevention and/or treatment of T2DM. More high-quality and long-term clinical trials are needed to confirm this evidence.
650 $aCucurbita
650 $aDiabetes mellitus
650 $aGlycemic control
650 $aPumpkins
653 $aFasting blood glucose
700 1 $aCÂNDIDO, F. G.
700 1 $aRAMOS, J. DE S.
700 1 $aGUILARDUCCI, M. J.
700 1 $aGUIMARÃES, N. S.
700 1 $aLIU, H.
700 1 $aGOMES, J. M. G.
773 $tNutrition Reviews, nuag027, apr. 2026.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Alimentos e Territórios (CNAT) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
|
| Registros recuperados : 2 | |
| 1. |  | CHERETTI, B. R.; SILVA, S. V. G.; KAZUYOSHI, R. N.; ALVES-SILVA, R. de A.; GUEDES, N. C.; SAMPAIO, F. G.; TERAMOTO, E. T.; BUENO, G. W. Avanços em IoT e sensores inteligentes no monitoramento limnológico e climático da aquicultura: uma revisão sistemática. In: CONGRESSO BRASILEIRO DE AQUICULTURA E BIOLOGIA AQUÁTICA, 11., 2025, Campos do Jordão. Conectando a ciência com a produção: anais [...]. Campos do Jordão: Aquabio, 2025. Aquaciência 2025. p. 775-776.| Tipo: Resumo em Anais de Congresso |
| Biblioteca(s): Embrapa Meio Ambiente. |
|    |
| 2. | | SILVA, S. V. G.; ALVES-SILVA, R. de A.; NAOE, R. K.; GUEDES, N. C.; DIAS, C. M. B.; CHERETTI, B. R.; SAMPAIO, F. G.; TERAMOTO, E. T.; GODÓI, F. C. M.; WOLFF, L. F. Protótipo de baixo custo para o monitoramento climático e da água em sistemas de produção aquícola. In: CONGRESSO BRASILEIRO DE AQUICULTURA E BIOLOGIA AQUÁTICA, 11., 2025, Campos do Jordão. Conectando a ciência com a produção: anais [...]. Campos do Jordão: Aquabio, 2025. Aquaciência 2025. p. 524-525.| Tipo: Resumo em Anais de Congresso |
| Biblioteca(s): Embrapa Meio Ambiente. |
| |
| Registros recuperados : 2 | |
|
| Expressão de busca inválida. Verifique!!! |
|
|
